Scilex Holding

AI Score

0

Unlock

0.17
-0.03 (-14.57%)
At close: Feb 10, 2025, 3:57 PM
0.17
0.00%
After-hours Feb 10, 2025, 05:00 PM EST
undefined%
Bid 0.08
Market Cap 76.25M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) n/a
PE Ratio (ttm) n/a
Forward PE n/a
Analyst n/a
Ask 0.32
Volume 20,282
Avg. Volume (20D) 12,689.546
Open 0.15
Previous Close 0.20
Day's Range 0.15 - 0.17
52-Week Range 0.15 - 0.17
Beta undefined

About SCLXW

Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain. The company's principal product includes ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain. It also offers SP-102 or SEMDEXA, a viscous gel formulation of corticosteroid f...

Sector Healthcare
IPO Date n/a
Employees 113
Stock Exchange NASDAQ
Ticker Symbol SCLXW
No News article available yet